CopyMark Law Group
4.9/5
Drawing for MONORAB

USPTO serial 87287352

MONORAB

Reviewed by CopyMark Law Group

Reg. 5325675Status 702Renewal
Filing date
Status date
Registration date
Oct 31, 2017
Examiner
BIBB, SCOTT
Law office
TMEG LAW OFFICE 109

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with MONORAB?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $748*

Plus Government fees of $1,300

Trademark Monitoring(312) 319-4460
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Start a new application
(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Yue (Robert) Xu

Yue (Robert) Xu Apex Attorneys at Law, LLP160 Alamo Plaza #942Alamo, CA 94507United States

Goods and services

ClassDescriptionStatusFirst use
001Biochemicals, namely, monoclonal antibodies for in vitro scientific and research use, and for therapeutic and diagnostic useACTIVEFeb 14, 2017
042Research and development in the biotechnology fields, namely, conducting custom monoclonal antibody productionACTIVEFeb 22, 2017

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 1, 2026REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED—
May 30, 2024EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
May 30, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
May 30, 2024ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
May 30, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 30, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Nov 6, 2023NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Nov 6, 2023C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Nov 6, 2023APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
May 9, 2023E815TEAS SECTION 8 & 15 RECEIVED—
Oct 31, 2022REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Sep 15, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Sep 15, 2022EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Sep 15, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 15, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Mar 3, 2021ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Jun 2, 2020CORVREVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED—
Apr 2, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Apr 2, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Apr 2, 2020ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Apr 2, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 2, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Apr 2, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Oct 31, 2017R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 29, 2017SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Sep 28, 2017FIXDELECTRONIC RECORD REVIEW COMPLETE—
Sep 22, 2017ERRRON HOLD - ELECTRONIC RECORD REVIEW REQUIRED—
Sep 20, 2017SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Sep 19, 2017CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Aug 25, 2017SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Aug 22, 2017AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jul 31, 2017IUAFUSE AMENDMENT FILED—
Jul 31, 2017EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Jul 4, 2017NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
May 9, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 9, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 19, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 28, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 28, 2017DOCKASSIGNED TO EXAMINER—
Jan 11, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 6, 2017NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance